Drug class in one race
JAK drugs for Ulcerative Colitis
2 tracked JAK drugs in the Ulcerative Colitis race. The class explanation lives on the JAK page; the full indication pipeline across every mechanism is on the Ulcerative Colitis page.
2 approved / phase 4
Head-to-head evidence: tofacitinib vs upadacitinib